
基于FDA不良事件报告系统数据库的新型四环素类抗菌药物不良反应信号比值失衡分析
Disproportionality analysis of adverse reaction signals for novel tetracycline antibiotics based on the FDA adverse event reporting system database
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |